GlaxoSmithKline
The multiyear agreement will focus on speeding clinical trials and drug development in oncology and nonalcoholic steatohepatitis.
Also: Truepill launches a COVID-19 test coverage platform for insurers, and 23andMe extends its partnership with GSK.
The partnership expands on the companies’ earlier collaboration announced in late 2019.
Funds will be used to acquire more data sets and develop AI analysis.
MobiHealthNews tracked investments, pilots, partnerships and app launches from major pharma companies during the quarter.